Heritage Global operates through two business units—Industrial Assets and Financial Assets—valuing and monetizing surplus and distressed industrial equipment, real estate, and charged-off loan portfolios. Its results are closely watched because the company is a "trailing benefactor" of economic conditions: layoffs, corporate restructurings, and rising non-performing loans ultimately translate into auction and asset-sale volume for the firm. After a second quarter weighed down by significant non-cash impairments, this report offered investors a chance to gauge whether the core, capital-light business is returning to consistent profitability. The rebound in industrial auction activity and the integration of recent acquisitions made the quarter a key read on the company's growth trajectory heading into 2027. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
For the third quarter ended September 30, 2026, Heritage Global reported total revenue of $14.6 million, a roughly 28% increase from $11.4 million in the same period of 2025. Net income came in at $1.0 million, or $0.03 per diluted share, up from $0.6 million, or $0.02 per diluted share, a year earlier. Diluted EPS of $0.03 was in line with consensus, while revenue exceeded the approximately $13.6 million analysts had projected.
Operating income was $1.0 million, slightly below the $1.3 million recorded in the prior-year quarter, and Adjusted EBITDA totaled $1.4 million versus $1.6 million a year ago. By segment, the Industrial Assets division delivered operating income of $1.5 million, up from about $0.9 million, reflecting healthy auction volume and a return of larger-scale transactions across transportation, metalworking, and semiconductor sectors. The Financial Assets division generated roughly $0.8 million in operating income, down from $1.6 million, as strength in the NLEX and newly acquired Boston Note businesses was offset by softer-than-expected results at DebtX.
Shares of HGBL closed at $1.26 on November 5, 2026, down about 1.6% in regular trading, but edged higher in after-hours trading following the release. The mixed market response reflects a quarter that beat on revenue and matched EPS expectations, yet showed a year-over-year decline in operating income and Adjusted EBITDA. Investor focus appeared split between the encouraging momentum in industrial auctions and lingering concerns about DebtX performance and the wind-down of the HGC specialty lending business. Management's commentary struck an optimistic tone, emphasizing a broadening auction pipeline and confidence in a strong finish to 2026.
Looking ahead, management pointed to a deepening industrial auction pipeline, with multiple large opportunities across sectors such as trucking, food processing, and medical devices. This diversification beyond the company's traditional biotech and pharmaceutical base is a key theme to watch, as it could support more consistent quarterly volume.
The company's $2 million joint venture investment in two Colorado pharmaceutical sites is another catalyst. Equipment auctions from those facilities are expected to generate revenue this year, but the more substantial real estate monetization—through lease, sale, or development—is not anticipated to contribute until 2027 or 2028. Investors will want to track how management chooses to realize value from these campuses.
On the Financial Assets side, DebtX remains a central focus. Management is expanding its sales force to capture opportunities in the commercial real estate (CRE) loan marketplace, where a large volume of maturing loans could create deal flow. Meanwhile, the wind-down of HGC is expected to remove a source of distraction and cost, sharpening focus on the core capital-light business. A new $10 million revolving credit facility with C3bank, running through January 2028, also strengthens balance-sheet flexibility as the company evaluates organic growth and selective acquisitions. From what I see, this is important because it provides more room to maneuver.
I frequently rely on Tickeron’s AI Screener to quickly filter stocks by fundamentals, technical patterns, and industry momentum. It helps surface comparable names and potential signals without spending hours on manual work, which has become a regular part of how I evaluate opportunities like this one.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 10-day moving average for HGBL crossed bearishly below the 50-day moving average on October 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for HGBL turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 37 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 88%.
HGBL moved below its 50-day moving average on October 29, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HGBL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
The Aroon Indicator for HGBL entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 45 of 66 cases where HGBL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 68%.
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on HGBL as a result. In 77 of 100 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 77%.
The 50-day moving average for HGBL moved above the 200-day moving average on October 26, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +3.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where HGBL advanced for three days, in 154 of 217 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
HGBL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. HGBL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 62 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.841) is normal, around the industry mean (3.008). P/E Ratio (-3.000) is within average values for comparable stocks, (6.695). Projected Growth (PEG Ratio) (0.100) is also within normal values, averaging (0.809). Dividend Yield (0.000) settles around the average of (9.358) among similar stocks. P/S Ratio (0.997) is also within normal values, averaging (16.899).
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HGBL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a company which engages in the provision of corporate and financial asset liquidation transactions, valuations, and advisory services
Industry InvestmentBanksBrokers